Patent registration applications for antihypertensive agents up

The Korean Intellectual Property Office (KIPO) says that the applications for the registration of antihypertensive agents have been gradually increased thanks to more intensive R&D efforts of pharmaceutical firms in the related field.

The KIPO notes that the antihypertensives-related patent applications filed since 1990 totaled 730 cases but despite some downward trends from 1993, have shown...